aggregated●·Stocks·

Musk vs. Altman Trial Opens as OpenAI Hits $850B Valuation — and Missed Targets

MSFTAMZNNVDAGOOGLMETA

Opening arguments began in the closely watched lawsuit brought by Elon Musk alleging that OpenAI and its leadership betrayed the company's founding non-profit mission while enriching themselves through billions in private fundraising. The trial arrives at an awkward moment: OpenAI is simultaneously defending a valuation of roughly $850 billion in court proceedings while reports surface that the company missed key growth targets — sending shares of OpenAI-linked stocks lower. Alongside the legal drama, OpenAI expanded its commercial reach by making its latest AI models and Codex coding agent available to AWS customers through Amazon Bedrock.

Why it matters

Investors with exposure to AI-adjacent stocks — particularly Microsoft, which holds a deep strategic stake in OpenAI — face headline risk as long as this trial runs. A ruling that OpenAI violated its non-profit charter could complicate its ongoing conversion to a for-profit structure, threatening the $40 billion fundraising round closed earlier this year and potentially forcing operational changes that slow its commercial momentum. The missed growth targets compound that uncertainty, signaling that even at $850 billion, execution risk is real.

Watch next

July 2025 (ongoing): Daily trial proceedings in Musk v. Altman — any ruling on injunctive relief could be immediate. Watch for OpenAI's next reported revenue or user-growth figures, which will either confirm or contradict the missed-targets narrative. Monitor Microsoft's (MSFT) next earnings call for commentary on OpenAI partnership economics.

Full analysis · Subscribers

The deep dive (bull case, bear case, and the data point that decides which side wins), the cause-and-effect chain behind the move, plain-English explainers for every block.

Want this for every market day?

Aggregated reads 51 sources in five languages and turns the day into plain-English cards like this one.

Educational analysis of public information — not investment advice.

← Today's brief